United States: Will Evaporated Cane Juice Be Sweet For Class Action Plaintiffs?

Last Updated: November 6 2014
Article by Jonathan Berman

The past few years have seen a remarkable growth in the number of class actions directed at food labels. Noteworthy about these cases is not merely how many have been filed but their nature as well. There's nothing novel about alleging that a product label (including a food label) is false or misleading. But many of the current cases focus not on the label's impact on consumers but on whether the label complies with the full regime of regulations that govern food labels. Indeed, many complaints assert that labels can be actionable because of an alleged regulatory violation, even in the absence of consumer deception. Dozens of pending complaints delve into rules familiar to food and drug regulatory lawyers but foreign to the vast majority of litigators.

This in turn leads to a host of questions that remain undeveloped in the case law (especially at the appellate levels). When does the misbranding of a product—a regulatory violation—create an actionable claim for consumers? When does compliance with regulations preempt a state-law cause of action? What is the impact of informal or nonbinding pronouncements of FDA officials? And what is the effect of the continued evolution of the regulatory law? 

Many of these issues come to the fore in the multitude of cases alleging the term "evaporated cane juice" ("ECJ")—used on a number of food products—is an unlawful description of added sugar. Nearly all of them are pending before the Ninth Circuit in a case described below. The controversy over ECJ is being hashed out by the courts and by the Food and Drug Administration ("FDA" or "Agency"), but in both jurisdictions, the question is whether ECJ is misleading: Does the name accurately convey to consumers what the ingredient actually is? 

Evaporated Cane Juice

Few, if any, ingredient names are currently more controversial than "evaporated cane juice." In recent years, sugar and other sweeteners have been vilified as empty calories, bad nutrition, and a significant contributor to the obesity rate. One scientist has gone so far as to call sugar a poison. In response, a new market for sweeteners has emerged, with consumers and companies alike trying to find the sweet spot between health-conscious eating and food that still satisfies consumers' tastes. Enter myriad alternative sweeteners: agave, honey, blackstrap molasses, stevia, raw sugar, and the controversial ECJ. 

ECJ, like plain sugar, is made from sugar cane. The primary difference between plain sugar, or white sugar, and ECJ is that white sugar undergoes a second crystallization process, during which it is stripped of molasses. A leading manufacturer of ECJ contends that its reduced processing leaves ECJ with a darker hue, a different flavor, and additional nutrients that are not present in refined white sugar. However, others in the sugar and sweetener industries, including the patent holder for sugar cane juice concentrate, disagree that ECJ is materially different from sugar, pointing out that the nutrient profiles are nearly identical. The term has been used in ingredient statements since at least 1998.

FDA Regulatory and Enforcement History of ECJ 

FDA laws and regulations require products to bear labels that are truthful and not misleading, which includes the requirement that each ingredient be declared by its common or usual name. FDA regulations require that "the common or usual name of a food, which may be a coined term, shall accurately identify or describe ... the basic nature of the food or its characterizing properties or ingredients. The name shall be uniform among all identical or similar products and may not be confusingly similar to the name of any other food that is not reasonably encompassed within the same name." The common or usual name of a food or ingredient can be established by common usage or by regulation. In the case of sugar, FDA regulations establish that sugar is the common or usual name for sucrose, and they define "sucrose" as "obtained by the crystallization from sugar cane or sugar beet juice that has been extracted by pressing or diffusion, then clarified and evaporated." The term "ECJ" is further complicated by FDA's heavy regulation of the term "juice," which is also defined by regulation.

In October 2009, FDA issued Draft Guidance for Industry: Ingredients Declared as Evaporated Cane Juice ("ECJ Draft Guidance"). Guidance documents are technically nonbinding policy statements indicating FDA's "current thinking" on any given subject. The Agency issues guidance documents to clarify statutory or regulatory requirements for industry, but, theoretically, they do not create new laws or regulations. Thus, FDA does not need to issue a guidance document on a subject in order to enforce the laws and regulations that pertain to the subject explained by a guidance document, and the document itself may reflect what FDA has been doing for some time. The public may comment on guidance documents at any time; however, FDA usually affords the public a specific comment period on a draft guidance in order to ensure those comments will be considered before FDA issues the final guidance.

The ECJ Draft Guidance is relatively short and serves to "advise the regulated industry of FDA's view that the term 'evaporated cane juice' is not the common or usual name of any type of sweetener, including dried cane syrup." FDA goes on to say that it considers the term ECJ to be false and misleading under the federal Food, Drug, and Cosmetic Act ("FDCA") because it fails "to reveal the basic nature of the food and its characterizing properties (i.e., that the ingredients are sugars or syrups)." Although FDA concedes that ECJ might be a juice in the broadest construction of the term, in the Agency's view, ECJ does not meet the definition of "juice" as contemplated by the regulation defining that term, nor as understood by consumers. FDA has received comments on the guidance document but has yet to finalize it. 

Although FDA issued the draft guidance only five years ago, the agency has been enforcing its underlying principles for at least 10 years. In 2004, FDA issued its first warning letter mentioning ECJ, stating "[y]our product label declares 'organic evaporated cane juice' in the ingredient list; however, the common or usual name for this ingredient is sugar." In another warning letter issued four years later, FDA reiterates that "'evaporated sugar cane juice' is not a common or usual name." Although the ECJ Draft Guidance has yet to be finalized, FDA nonetheless directed two food manufacturers to the document "for the proper way to declare [ECJ]" in two warning letters issued in 2012. None of the warning letters was issued solely for the ECJ ingredient labeling violation, nor was ECJ even the most egregious of the violations described in these warning letters, but the ECJ mentions are nonetheless informative. Plaintiffs frequently use warning letters as proof of FDA's interpretation of certain regulations, in spite of the fact that the Agency adamantly contends that these letters are informal administrative action, not subject to judicial review. 

FDA does not appear to have taken any additional enforcement action on ECJ since the last warning letters were issued in 2012. In March 2014, citing the desire to obtain additional data and information about ECJ and how it is manufactured, FDA reopened the comment period on the ECJ Draft Guidance. Most of the comments submitted during both comment periods are from industry and support the idea that ECJ is the common and usual name of an ingredient that is distinct from sugar, and that FDA should withdraw the draft guidance and discontinue any further enforcement action against ECJ. Still, a small but vocal minority of commenters, who claim to represent consumer concerns, hold firm that FDA should prohibit the term ECJ and require a term that more clearly indicates that the product is a crystallized sugar, arguing that the use of the term ECJ leads consumers to believe that the sweetener is a healthier version of sugar. FDA, which has been known to take years to finalize guidance documents, has not indicated when the Agency will take action on the ECJ Draft Guidance. At the end of the day, the ongoing litigation may effectively come to control how the sweetener is presented to consumers.

Consumer Protection Standards and Litigation

California's Consumer Protection Laws

California's consumer protection laws remain particularly relevant for food label suits, and the current wave of ECJ suits is no exception. In particular, class action plaintiffs have flocked to the Northern District of California, which some have nicknamed the "Food Court." This popularity stems from a combination of reasons. First, California's Sherman Food Drug & Cosmetics Law ("Sherman Law") and the California Health & Safety Code regulations, which expressly adopted the requirements of the FDCA and the Nutritional Labeling and Education Act, offer several benefits to plaintiffs. 

The Sherman Law, unlike the FDCA, provides plaintiffs with a private right of action via the California Unfair Competition Law ("UCL"), the False Advertising Law ("FAL"), and the Consumer Legal Remedies Act ("CLRA"). Plaintiffs claim that this private right of action allows plaintiffs to base a lawsuit on alleged technical violations of FDA regulations. Defendants' arguments that such claims are preempted by the FDCA have been rejected by some district courts, although the issue remains unresolved at the appellate level. 

Other plaintiffs take advantage of the fact that certain words, such as "natural," have not been defined by FDA. They claim that a food is not natural if overly processed, or if its ingredients are derived from genetically modified organisms. Plaintiffs use the Sherman Law, UCL, FAL, and CLRA as the basis for liability when they can allege that the products fall short of the federal requirements for making these food label claims. 

Other factors contribute to the Northern District's popularity. California houses the largest concentration of consumers. Food and beverage class actions usually involve very small individual claims for relief, but the per-plaintiff multipliers can be huge in a state like California, potentially containing more than 80 million consumers, or 12 percent of the U.S. population.

ECJ Suits

ECJ cases are common in the Northern District of California. These cases allege that defendants misleadingly describe sugar as ECJ. Plaintiffs often rely on the 2009 FDA draft guidance as their theory of recovery, arguing that FDA has advised industry not to refer to cane sugars as ECJ because it is not a juice as defined in the regulations. 

Dismissals of ECJ suits have often hinged on the issue of primary jurisdiction. The primary jurisdiction doctrine allows courts to stay proceedings or dismiss complaints without prejudice pending the resolution of an issue within the special competence of an administrative agency. Courts apply this doctrine when questions of fact require specific administrative expertise or discretion, or when the uniformity of a ruling is required in the interest of broader regulation. Essentially, even though the court could decide an issue, the court will defer to the relevant agency to make the determination. 

Before March 2014, primary jurisdiction challenges to these cases had been largely unsuccessful. Courts concluded that existing FDA regulations requiring labels to use the "common or usual name of food" were sufficient for the courts to decide the case, even though FDA was still developing its guidance on ECJ. After FDA reopened the comment period for the ECJ Draft Guidance in March 2014, the courts reversed course. At least 12 courts in the Northern District either stayed or dismissed cases based on FDA's primary jurisdiction over the issue. 

A dismissal based on primary jurisdiction, however, is often only a temporary victory. As noted, these dismissals are generally without prejudice. The case might therefore resurface if FDA comes to an unhelpful conclusion, or even if too much time elapses before FDA says anything at all.

Although most ECJ suits have been dealt with on the grounds of primary jurisdiction, at least one has not: Kane v. Chobani. Kane may prove to be the most important of all these cases, as it seeks to answer many of the questions mentioned above that are yet unresolved in the case law. It is pending in the Ninth Circuit, and it provides the Ninth Circuit with a vehicle to decide a number of issues that could control the outcome of dozens of cases still working their way through the Northern District. This case, in particular, tests the plaintiff's theory that a regulatory violation in all cases means that there has been a violation of consumer protection laws. This theory has failed numerous times in the Northern District, but this is the Ninth Circuit's first opportunity to address the issue in the context of the current wave of food label cases. 

In Kane, the plaintiff brought claims under the Sherman Law, CLRA, UCL and FAL, alleging, among other claims, that defendant's yogurt labels were deceptive because the labels do not identify ECJ as sugar. Plaintiffs asserted that they did not know ECJ was sugar and instead believed the sugar content declared in the yogurts' nutrition facts panel was naturally occurring, rather than added, and that they would not have purchased the products if they had known. 

On February 20, 2014, the Northern District granted defendant's motion to dismiss with prejudice, holding that plaintiffs had not sufficiently proven standing. Under the California consumer protection laws, plaintiffs must show reliance and damage. The court found that because plaintiffs admitted they understood "dried cane syrup" to be sugar and could not "explain what they believed evaporated cane juice to be, if not a form of sugar," plaintiffs' assertion that they did not understand the same of ECJ was implausible. 

On appeal to the Ninth Circuit, the plaintiffs/appellants argue that the district court erred in dismissing their claims because FDA guidance documents and warning letters put industry on notice that ECJ is a false and misleading ingredient name and therefore not legally permissible on food labels. The Ninth Circuit will have the chance to weigh in on whether ECJ is a deceptive term.

Other Means of Consumer Protection

Although these vehicles of consumer protection have not yet been utilized, both Section 5 of the Federal Trade Commission Act ("FTC Act") and "little FTC Acts" enforced by state attorneys general allow for government-initiated litigation. Section 5 of the FTC Act prohibits unfair or deceptive acts or practices. Under Section 5, FTC could bring actions against food manufacturers who label their products as containing ECJ, rather than sugar, if FTC were to determine that the term ECJ is likely to mislead a consumer acting reasonably under the circumstances, as long as the action is material (i.e., affects the consumer's decision to purchase the product). 

Attorneys general can likewise bring lawsuits pursuant to state laws prohibiting unfair or deceptive acts or practices. Alternatively, attorneys general can use their parens patriae authority, an authority held by states and exercised by attorneys general to protect state interests. It is an open question whether attorneys general may use their parens patriae authority to sue the food industry, similar to the theory used during the tobacco litigation.


The ECJ litigation underscores the uneasy mesh between the judicial and administrative processes. While, at the highest level, these systems generally seek to protect consumers, they operate on different timetables, using different procedures and different substantive rules of decision. 

FDA could potentially resolve the issue, but with no deadline for a final guidance and a history of lengthy consideration periods, courts might not wait for FDA to weigh in. Furthermore, in previous situations where courts have sought input from FDA, for example in defining "natural" in relation to "genetically modified ingredients," FDA has politely declined to provide clarification. This situation may be different, however, in that FDA appears to be actively pursuing a policy that would directly inform the court's decision.

FDA, which in some ways has more flexible tools than a court, may moot the debate through newly proposed and broadly applicable nutrition labeling requirements. Given that a central issue surrounding ECJ is whether consumers can properly identify the ingredient as a sugar, enhanced labeling may provide a path to clearer understanding. If the proposed labeling requirements were finalized, FDA would require manufacturers to declare added sugars on the Nutrition Facts Panel, eliminating the confusion alleged in the Kane litigation.

The ECJ cases reflect only one of many label claims challenged in the new misbranding class actions. Many of these cases, and many of the ones that may follow, will be wars fought on two fronts, and they will require defendants to muster expertise in both litigation and food regulation.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Jonathan Berman
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:
  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.
  • Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.
    If you do not want us to provide your name and email address you may opt out by clicking here
    If you do not wish to receive any future announcements of products and services offered by Mondaq you may opt out by clicking here

    Terms & Conditions and Privacy Statement

    Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

    Use of www.mondaq.com

    You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


    Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

    The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


    Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

    • To allow you to personalize the Mondaq websites you are visiting.
    • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
    • To produce demographic feedback for our information providers who provide information free for your use.

    Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

    Information Collection and Use

    We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

    We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

    Mondaq News Alerts

    In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


    A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

    Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

    Log Files

    We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


    This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

    Surveys & Contests

    From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


    If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


    From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

    *** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


    This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

    Correcting/Updating Personal Information

    If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

    Notification of Changes

    If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

    How to contact Mondaq

    You can contact us with comments or queries at enquiries@mondaq.com.

    If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.

    By clicking Register you state you have read and agree to our Terms and Conditions